These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 18378006
41. A subtype of multiple sclerosis defined by an activated immune defense program. van Baarsen LG, van der Pouw Kraan TC, Kragt JJ, Baggen JM, Rustenburg F, Hooper T, Meilof JF, Fero MJ, Dijkstra CD, Polman CH, Verweij CL. Genes Immun; 2006 Sep; 7(6):522-31. PubMed ID: 16837931 [Abstract] [Full Text] [Related]
42. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases. Brettschneider J, Jaskowski TD, Tumani H, Abdul S, Husebye D, Seraj H, Hill HR, Fire E, Spector L, Yarden J, Dotan N, Rose JW. J Neuroimmunol; 2009 Dec 10; 217(1-2):95-101. PubMed ID: 19879655 [Abstract] [Full Text] [Related]
45. Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population. Yang LL, Hua Q, Liu RK, Yang Z. Arch Med Res; 2009 Feb 10; 40(2):89-96. PubMed ID: 19237017 [Abstract] [Full Text] [Related]
52. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis. Battaglini M, Giorgio A, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N. J Neurol Sci; 2009 Jul 15; 282(1-2):55-60. PubMed ID: 19286193 [Abstract] [Full Text] [Related]
54. An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis. Koutsis G, Panas M, Giogkaraki E, Karadima G, Sfagos C, Vassilopoulos D. Mult Scler; 2009 Feb 15; 15(2):174-9. PubMed ID: 18805838 [Abstract] [Full Text] [Related]
57. Blood glutamate EAAT2-cell grabbing therapy in cerebral ischemia. Pérez-Mato M, Iglesias-Rey R, Vieites-Prado A, Dopico-López A, Argibay B, Fernández-Susavila H, da Silva-Candal A, Pérez-Díaz A, Correa-Paz C, Günther A, Ávila-Gómez P, Isabel Loza M, Baumann A, Castillo J, Sobrino T, Campos F. EBioMedicine; 2019 Jan 15; 39():118-131. PubMed ID: 30555045 [Abstract] [Full Text] [Related]
59. Tumour necrosis factor alpha gene (TNF-alpha) -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis. Losonczi E, Bencsik K, Nagy ZF, Honti V, Szalczer E, Rajda C, Illés Z, Mátyás K, Rózsa C, Csépány T, Füvesi J, Vécsei L. J Neuroimmunol; 2009 Mar 31; 208(1-2):115-8. PubMed ID: 19201038 [Abstract] [Full Text] [Related]
60. Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis. Fainardi E, Castellazzi M, Tamborino C, Trentini A, Manfrinato MC, Baldi E, Tola MR, Dallocchio F, Granieri E, Bellini T. Mult Scler; 2009 May 31; 15(5):547-54. PubMed ID: 19318509 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]